The present paper deals with the problem of allocating patients to two competing treatments in the presence of covariates or prognostic factors in order to achieve a good trade-off among ethical concerns, inferential precision and randomness in the treatment allocations. In particular we suggest a multipurpose design methodology that combines efficiency and ethical gain when the linear homoscedastic model with both treatment/covariate interactions and interactions among covariates is adopted. The ensuing compound optimal allocations of the treatments depend on the covariates and their distribution on the population of interest, as well as on the unknown parameters of the model. Therefore, we introduce the reinforced doubly-adaptive biased c...
For clinical trials that compare two or more competing treatments, the literature proposes several r...
In recent years, several authors have investigated allocation rules for comparative clinical trials,...
In recent years, several authors have investigated allocation rules for comparative clinical trials,...
The present paper deals with the problem of allocating patients to two competing treatments in the p...
This paper deals with the problem of allocating patients to two competing treatments in the presence...
This paper deals with the problem of allocating patients to two competing treatments in the presence...
This paper deals with the problem of allocating patients to two competing treatments in the presence...
The present paper deals with sequential designs intended to balance the allocations of two competing...
The present paper deals with sequential designs intended to balance the allocations of two competing...
The present paper deals with sequential designs intended to balance the allocations of two competing...
For clinical trials that compare two or more competing treatments, the literature proposes several r...
none3For clinical trials that compare two or more competing treatments, the literature proposes seve...
For clinical trials that compare two or more competing treatments, the literature proposes several r...
For clinical trials that compare two or more competing treatments, the literature proposes several r...
none3For clinical trials that compare two or more competing treatments, the literature proposes seve...
For clinical trials that compare two or more competing treatments, the literature proposes several r...
In recent years, several authors have investigated allocation rules for comparative clinical trials,...
In recent years, several authors have investigated allocation rules for comparative clinical trials,...
The present paper deals with the problem of allocating patients to two competing treatments in the p...
This paper deals with the problem of allocating patients to two competing treatments in the presence...
This paper deals with the problem of allocating patients to two competing treatments in the presence...
This paper deals with the problem of allocating patients to two competing treatments in the presence...
The present paper deals with sequential designs intended to balance the allocations of two competing...
The present paper deals with sequential designs intended to balance the allocations of two competing...
The present paper deals with sequential designs intended to balance the allocations of two competing...
For clinical trials that compare two or more competing treatments, the literature proposes several r...
none3For clinical trials that compare two or more competing treatments, the literature proposes seve...
For clinical trials that compare two or more competing treatments, the literature proposes several r...
For clinical trials that compare two or more competing treatments, the literature proposes several r...
none3For clinical trials that compare two or more competing treatments, the literature proposes seve...
For clinical trials that compare two or more competing treatments, the literature proposes several r...
In recent years, several authors have investigated allocation rules for comparative clinical trials,...
In recent years, several authors have investigated allocation rules for comparative clinical trials,...